Could home monitoring replace half of clinic visits for lung fibrosis?

NCT ID NCT06883448

Recruiting now Knowledge-focused Sponsor: Erasmus Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether people with pulmonary fibrosis can safely replace half of their regular clinic visits with home monitoring. Participants will use a home spirometer, pulse oximeter, and a smartphone app to track their health and communicate with their care team. The goal is to see if this approach helps patients better manage their own health while reducing the burden of frequent hospital visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: home monitoring care (spirometer, pulse oximeter, app)
What this could lead to: If successful, this could show that home monitoring is a safe and effective way to reduce hospital visits for people with pulmonary fibrosis, improving their quality of life.
What could go wrong: This is an early-stage implementation study with no direct treatment. It may not show clear benefits, and results may not apply to all patients or healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE (ILD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERSTITIAL LUNG DISEASE (ILD) PULMONARY FIBROSIS

Contacts and locations

Locations

Department of Pulmonary Diseases, Rijnstate Hospital
RECRUITING

Arnhem, Netherlands
Department of Pulmonary Medicine, Zuyderland Medical Centre
RECRUITING

Heerlen, Netherlands
Department of Pulmonology, Haaglanden Medisch Centrum
RECRUITING

The Hague, Netherlands
Department of Pulmonology, Leiden University Medical Center
RECRUITING

Leiden, Netherlands
Department of Pulmonology, Medical Center Leeuwarden
RECRUITING

Leeuwarden, Netherlands
Department of Pulmonology, Onze Lieve Vrouwe Gasthuis
RECRUITING

Amsterdam, Netherlands
Department of Respiratory Medicine, Amphia Hospital
RECRUITING

Breda, Netherlands
Department of Respiratory Medicine, Catharina Hospital
RECRUITING

Eindhoven, Netherlands
Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center
RECRUITING

Rotterdam, Netherlands
Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University
RECRUITING

Utrecht, Netherlands
Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital
RECRUITING

Nieuwegein, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.